Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review. | Int J Mol Sci | 2023 | 36674968 | PubTator, text mining | PubMed |
| An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma. | Genes (Basel) | 2023 | 36672865 | PubTator, text mining | PubMed |
| Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma. | Mol Med Rep | 2023 | 36660936 | PubTator, text mining | PubMed |
| Advances of mRNA vaccine in tumor: a maze of opportunities and challenges. | Biomark Res | 2023 | 36650562 | PubTator, text mining | PubMed |
| A signature of immune-related genes correlating with clinical prognosis and immune microenvironment in sepsis. | BMC Bioinformatics | 2023 | 36650470 | PubTator, text mining | PubMed |
| Multifunctional Integrated Nanozymes Facilitate Spinal Cord Regeneration by Remodeling the Extrinsic Neural Environment. | Adv Sci (Weinh) | 2023 | 36646515 | PubTator, text mining | PubMed |
| Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression. | Cold Spring Harb Mol Case Stud | 2023 | 36639200 | PubTator, text mining | PubMed |
| Multi-omics characterization of a scoring system to quantify hypoxia patterns in patients with head and neck squamous cell carcinoma. | J Transl Med | 2023 | 36627705 | PubTator, text mining | PubMed |
| Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells. | Mol Ther Methods Clin Dev | 2023 | 36620075 | PubTator, text mining | PubMed |
| Cell Pair Algorithm-Based Immune Infiltrating Cell Signature for Improving Outcomes and Treatment Responses in Patients with Hepatocellular Carcinoma. | Cells | 2023 | 36611994 | PubTator, text mining | PubMed |
| METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. | Cell Stem Cell | 2023 | 36608679 | PubTator, text mining | PubMed |
| Inducing trained immunity in pro-metastatic macrophages to control tumor metastasis. | Nat Immunol | 2023 | 36604547 | PubTator, text mining | PubMed |
| Dysfunctional epigenetic protein-coding gene-related signature is associated with the prognosis of pancreatic cancer based on histone modification and transcriptome analysis. | Sci Rep | 2023 | 36599884 | PubTator, text mining | PubMed |
| Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. | Blood Cancer J | 2023 | 36599826 | PubTator, text mining | PubMed |
| Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance. | Cell Rep Med | 2023 | 36599351 | PubTator, text mining | PubMed |
| Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation. | Nat Commun | 2023 | 36596811 | PubTator, text mining | PubMed |
| CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. | Immunity | 2023 | 36580918 | PubTator, text mining | PubMed |
| Long-term Findings in Bullous Sarcoidosis: A Case Report and Literature Review. | Intern Med | 2023 | 36543217 | PubTator, text mining | PubMed |
| Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis. | J Immunol | 2023 | 36542831 | PubTator, text mining | PubMed |
| Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir. | Nat Immunol | 2023 | 36536105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=28